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ABSTRACT A permanent human cell line, EA hy 926, has been
established that expresses at least one highly differentiated func-
tion of vascular endothelium, factor VII-related antigen. This line
was derived by fusing human umbilical vein endothelial cells with
the permanent human cell, line A549. Hybrid cells that survived
in selective medium had more chromosomes than either progen-
itor cell type and included, a marker. chromosome from the A549
line. Factor VIII-related antigen can be identified intracellularly
in the hybrids by immunofluorescence and accumulates in the cul-
ture fluid. Expression of factor VIH-related antigen by these hy-
brid cells has been maintained for more than 100 cumulative pop-
ulation doublings, including more than 50 passages and three cloning
steps. This is evidence that EA-hy 926 represents a permanent line.
Differentiated functions of endothelium are critical for the vas-
cularization process in normal and neoplastic tissue, for main-
taining the blood-brain barrier, and for hemostasis. Factor VIII-
related antigen (VIIIR:Ag) is an endothelial cell product (1) in-
volved in the aggregation of platelets, and megakaryocytes are
the only other cell type known to express this antigen (2).
VIIIR:Ag is present in normal human plasma at about 10 pug/
ml, and decreased levels are found in classical von Willebrand
disease, an autosomal dominantly inherited bleeding disorder
in humans. VIIIR:Ag circulates as a large molecular complex
and its platelet-aggregating activity is directly related to the size
distribution of the complex (3). Factor VIII coagulant activity
(antihemophilic factor) is also associated with the VIIIR:Ag
complex in plasma. The detailed composition and stoichio-
metrics of the complex are still unclear. Heterologous anti-
bodies produced in response to immunization with the plasma
factor VIII complex have defined the major VIIIR:Ag and have
demonstrated its presence in the cells that line vascular lumina.
Such endothelial cells derived from human umbilical veins have
been shown to synthesize VIIIR:Ag in culture (1). However,
the survival of these differentiated cells in culture is quite lim-
ited and is dependent on special culture parameters and growth
factors (4).
There are relatively few permanent cell lines that express
facultative traits of tissues from which they were derived. Hu-
man differentiated cell lines are especially valuable because the
types of experiments that can be conducted in vivo are further
limited by ethical considerations. Permanent cell lines that ex-
press differentiated functions have perhaps most often been
derived from tumors of differentiated cells, such as plasma-
cytomas. Somatic cell hybridization has also been used to im-
mortalize certain facultative traits in culture, hybridomas (5)
being the most renowned examples of this tactic. However, dif-
ferentiated functions are most often extinguished in hybrid cells
(6), and the principles that govern whether a function is extin-
guished or retained are. not yet clear.
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We have previously described interspecies hybrids between
human endothelial cells and a number of rodent cell lines, in
which VIIR:Ag was not expressed (7). There has also been a
preliminary report by others (8) of human-rodent hybrids that
may express VIIIR:Ag, but the intracellular distribution of an-
tigenicity that they detect is not similar to that of VIIIR:Ag in
endothelial cells.
Here we report a human intraspecies hybrid, EA-hy 926, that
expresses VIIIR:Ag with the same morphological distribution
as in primary endothelial cells.
MATERIALS AND METHODS
Cell Culture. Cells were cultured on plastic ware at 370C in
a humid atmosphere containing 7% CO2 in air. Culture me-
dium was exchanged every 3-5 days. At confluence, 0.01%
trypsin (TRL Worthington, no. LSOO 044 52) in 8 mM phos-
phate-buffered saline (pH 7.4) with 0.54 mM EDTA and 5.5
mM glucose was used to detach the cells, which were then sub-
cultured at lower cell density.
Human umbilical vein endothelial cells (HUV-EC) were iso-
lated as described in detail by Gimbrone (9). The vein of an
umbilical cord kept at 40C for 4 hr postpartum was irrigated
with phosphate-buffered saline. The endothelial cells were dis-
sociated from the vessel wall with 0.1% collagenase (Sigma, no.
C2139) in phosphate-buffered saline at 370C for 20 min. The
cells were separated from the collagenase solution by centrif-
ugation and were distributed over 60 cm2 in RPMI 1640 me-
dium (GIBCO, no. 430-1800) with 15% heat-inactivated fetal
bovine serum, 0.01 mM thymidine (10), penicillin at 100 units/
ml, and streptomycin at 100 ,pg/ml. A portion of the medium
(15%) had been preconditioned for 2 days by actively growing
BALB/c 3T3 cells (11), followed by 0.45-gm filtration.
A549 cells were originally derived by Lieber et al (12) from
a human lung carcinoma. Cells of a hypoxanthine phosphori-
bosyltransferase-deficient clone, A549/8 (13), were cultured in
the presence of 0.1 ,uM 6-thioguanine in Dulbecco's modified
Eagle medium (GIBCO, no. 430-1600) supplemented with 5%
heat-inactivated fetal bovine serum. These cells died in HAT
[100 p.M hypoxanthine/0.4 AM aminopterin/16 A.M thymi-
dine (14)].
Rhodamine 6G (Eastman Organic Chemicals, no. 10724) was
added at 1 pug/ml to A549/8 culture 3 days before hybridization
in an attempt to increase the yield of viable hybrids, as sug-
gested by the work of Ziegler and Davidson (15).
Hybridization. A confluent 55-cm2 dish of rhodamine 6G-
treated A549/8 cells and a dish of first-passage HUV-EC were
trypsinized and combined in used culture medium in a round-
bottomed tube. The cells were pelleted together at 350 x g for
Abbreviations: VIIIR:Ag, factor VIII-related antigen; HUV-EC, human
umbilical vein endothelial cells; HAT, 100 ,uM hypoxanthine/0.4 AuM
aminopterin/16 tLM thymidine.
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5 min, resuspended in serum-free medium, and centrifuged
again. After all but a drop of the supernatant had been removed
by aspiration, the cells were resuspended and 0.5 ml of 50%
(wt/vol) polyethylene glycol of Mr 1,000 (Koch Light) was added.
The suspension was centrifuged for 3 min at 125 X g; then 5
ml of serum-free medium was added gradually, and the cells
were gently swirled for 3 min before centrifuging again at 350
X g for 5 min. The cell pellet was resuspended in endothelial
cell medium and distributed to four dishes at varying densities.
At the same time, rhodamine 6G-treated A549/8 cells alone
were treated with polyethylene glycol in the same way and dis-
tributed to two dishes. Four days after fusion, the culture me-
dium was changed to include HAT.
VfIiR:Ag Assays. Fluorescein-labeled goat antibody was used
in a direct immunofluorescent assay to detect intracellular
VIIIR:Ag. This antibody preparation has been shown to be spe-
cific for the component of normal human plasma that is missing
in severe von Willebrand disease plasma (7). A mouse mono-
clonal antibody to VIIIR:Ag (16) was used in an indirect im-
munofluorescent assay. The primary monoclonal antibody was
visualized by using a fluorescein-labeled affinity-purified goat
antibody to mouse immunoglobulin (Bionetics, no. 8608-13).
Cells to be assayed were grown on no. 1 glass coverslips, fixed
in acetone, exposed to the antibodies, and washed in phos-
phate-buffered saline. Fluoresceinated antibodies that bound
to cells were detected microscopically by incident light exci-
tation and observation through a Leitz H2 filter system.
VIIIR:Ag in the medium removed from cell cultures was as-
sayed by Laurell immunoelectrophoresis by using a rabbit an-
tibody to VIIIR:Ag (17). The immunoprecipitates were visu-
alized by using peroxidase-conjugated swine antibodies to rabbit
immunoglobulins (Accurate Chemicals, no. P217) and 3-amino-
9-ethylcarbazole as substrate.
von Willebrand factor activity was assayed as ristocetin-de-
pendent platelet agglutination (18).
Chromosomes. Chromosomes were spread and stained as
described by Hsu (19). For counting, spreads within disks of
cytoplasm were selected, and care was taken to avoid counting
a single spread more than once. Modal chromosome numbers
were determined on the basis of chromosome counts of 50 cells.
RESULTS
When rhodamine 6G-treated A549/8 cells were mixed with
primary endothelial cells and subjected to polyethylene glycol
fusion and then plated in HAT-supplemented medium, all four
subcultures continued to survive for many weeks after both of
the control cultures of treated A549/8 cells had disintegrated.
After 6 wk, each culture was replated at a density of 1:10 to
eliminate the possibility that survival was dependent on cross
feeding. The cultures continued to expand slowly but at a grad-
ually increasing rate for the next few passages. Cellular mor-
phology was varied and unlike either progenitor type.
Fusion-derived cells were first assayed for VIIIR:Ag after 14
wk and four passages. A large fraction of the cells in each of the
four sublines was found to be VIIIR:Ag-positive. At this stage
the cells were cloned and VIIIR:Ag-positive cells were found
in eight of eight subelones. One of these subclones, EA-hy 926,
was continuously expanded and additional subclones were iso-
lated after 30 more passages. At least 16 of 17 clones had
VIIIR:Ag-positive cells at this stage also.
Results of the direct immunofluorescent assay indicating
VIIIR:Ag in fusion-derived cells are presented in Fig. 1 along
with appropriate controls for specificity. VIIIR:Ag in the fu-
sion-derived cells was found to be distributed extranuclearly in
discrete bead formations, indistinguishable from its morpho-
logical distribution in primary endothelial cells. The other pro-
genitor cell line, A549/8, was negative for VIIIR:Ag. Results
of the direct immunofluorescent assay with a polyclonal goat
antibodv were confirmed bv the indirect assav with monoclonal
mouse antibody to VIIIR:Ag.
VIIIR:Ag was found to accumulate in the culture medium of
fusion-derived cells as shown in Fig. 2. von Willebrand factor
activity was also detected in the culture medium from these
cells at a level similar to that in primary HUV-EC culture me-
dium. For both types of cells, the sizes of the platelet aggre-
gates formed were rather small.
Despite the expression of this highly differentiated function,
the fusion-derived cells were not thought to be descended from
the endothelial cells alone, because they continued to expand
far beyond the survival time of any of the other hundreds of
endothelial cell cultures established in this laboratory. To dem-
onstrate that the cells were indeed hybrids, the chromosomes
were examined and counted. Shortly after fusion, at a cumu-
lative population doubling level of 10, the modal chromosome
number of hybrid line EA-hy 920 was 100, a number close to
the sum of 61 chromosomes from an A549/8 cell and 46 chro-
mosomes from a normal human diploid endothelial cell. Sub-
sequently, the modal chromosome number of subelone EA-hy
926 stabilized around 80, as shown in Fig. 3. At each stage, a
large dicentric-like marker chromosome originating in A549 cells
was observed in most spreads.
These hybrid cells have quite vigorous growth properties.
They have been in culture for many population doublings be-
yond the level at which nonpermanent cell lines generally suc-
cumb to senescence. Population doubling level here refers to
the logarithms of the relative expansions in area of confluent
cells at each passage. It has not been corrected for <100% at-
tachment efficiency and is therefore an underestimate. When
the cumulative population doubling level was 52, EA hv 926
cultures were determined to have a doubling time of 12 hr and
to attain a density of 105 cells per cm2. The cloning efficiency
was 21% at a cumulative population doubling level of 109, and
cells reached confluency again within a week when 1/16th of
a confluent culture was passed to a new dish. The Hoechst 33258
test (20) for mycoplasma contamination of these cultures was
negative.
CONCLUSIONS AND DISCUSSION
We have described sustained expression of VIIIR:Ag, the prod-
uct of a highly differentiated tissue, in a continuous cell line.
There has been no persistent change in the fraction of antigen-
positive cells during >100 population doublings since this cell
line was constructed by hybridization. Because most chromo-
some segregation from hybrid cells occurs soon after fusion,
and intraspecies hybrids are known to be relatively stable (21),
we expect expression of VIIIR:Ag to persist indefinitely in these
hybrid cells.
Absolute criteria for predicting the immortality of a cell line
are not established. Clonal endothelial lines isolated from fetal
bovine aorta have been shown (22) to have a life span limited
to about 80 population doublings under normal culture con-
ditions similar to those described here. The survival of human
endothelial cells in culture has generally been found to be much
more limited than that of bovine cells. However, the hvbrid
human cells described here do not appear to have the limited
expansion potential characteristic of normal diploid cells be-
cause they have already reached >100 population doublings.
The fact that the growth rate of these cells has gradually in-
creased ever since their isolation is further reason to believe
that the hybrids represent a permanent line.
There is precedent for immortalizing genetic traits in culture
by hybridization of normal cells with cells of permanent lines.
However, most often, only constitutive ("housekeeping") func-
tions continue to be expressed in hybrid cells (6). VIIIR:Ag is
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a facultative ("differentiated") function normally expressed only
in endothelial cells and megakaryocytes. We previously fused
human vascular endothelial cells to cells of 10 different rodent
lines and isolated hundreds of interspecies hybrid clones, none
of which sustained the expression of human VIIIR:Ag (7). The
VIIIR:Ag-positive hybrids described here are intraspecies hy-
FIG. 1. Cells stained for VIIR:Ag with fluoresceinated antibodies. (a) Primary HUV-EC were stained directly with fluoresceinated goat an-
tibody to VIIIR:Ag preabsorbed with severe von Willebrand plasma, which does not remove the antibodies to VMR:Ag. (b) Primary HUV-EC were
treated similarly with fluoresceinated goat antibody to VIIIR:Ag but preabsorbed with normal plasma, which removed the antibodies to VIIIR:Ag.
(c) A549/8 cells treated with fluoresceinated goat antibody to VIIIR:Ag do not bind the antibody. (d) Hybrid cells, EAhy 926, were treated similarly
with fluoresceinated goat antibody to VIIIR:Ag preabsorbed only with severe von Willebrand plasma. (e) Hybrid cells, EAhy 926, were stained
indirectly by using monoclonal antibody to VIIIR:Ag as the primary reagent and fluoresceinated goat antibody to mouse immunoglobulin as the
secondary reagent. (f) Hybrid cells, EA'hy 926, were treated similarly but with normal mouse serum as the primary reagent and the same flu-
oresceinated goat antibody to mouse immunoglobulin as the secondary reagent.
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FIG. 2. Rockets of immunoprecipitates were formed by electropho-
resis of 20-,ul samples through an agarose gel containing 0.25% anti-
serum to VIIIR:Ag and were visualized by using a peroxidase-conju-
gated secondary antibody. Dilutions of pooled normal plasma are shown
as standards on the left. Culture medium samples are shown on the right
after various intervals of exposure to confluent EA-hy 926 cultures at
0.1 ml/cm2.
brids, which may be significant in the sustained expression of
this differentiated function.
Another feature of this cell fusion that may have been sig-
nificant to the sustained expression of VIIIR:Ag was the pre-
treatment of the A549/8 cells-with rhodamine 6G. Ziegler and
Davidson (15) have shown that rhodamine 6G could favorably
influence the yield of viable hybrids from certain cell lines and
that it eliminated mitochondrial genetic determinants. This agent
may also influence the direction of chromosomal segregation in
hybrid cells (23). It is conceivable that rhodamine 6G pretreat-
ment can effect the sustained expression of a number of dif-
ferentiated functions in hybrid cells.
To test whether the expression of VIIIR:Ag in hybrids of
primary endothelial cells and A549/8 cells is affected by pre-
treatment of the A549/8 cells with rhodamine 6G, equal por-
tions of an endothelial cell preparation were fused with rho-
damine 6G-treated and untreated cultures of the permanent
cell line. No viable hybrids were detected. The hybrid yield
from fusions involving primary cell lines depends, of course,
upon the vigor of the particular cell preparation used. The sub-
stantial yield of hybrids described in this report resulted from
a fusion involving a primary endothelial cell preparation and
only rhodamine 6G-treated A549/8 cells. In eight previous at-
tempts to fuse primary endothelial cells and A549/8 cells with-
out rhodamine 6G pretreatment, no viable hybrids had been
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FIG. 3. The modal chromosome number in EA-hy 926 is shown at
various intervals after fusion. The first point represents EA-hy 920 be-
fore its subclone EA-hy 926 was isolated. The mean chromosome num-
bers are indicated by the positions of the horizontal bars, and the ver-
tical lines represent 2 SDs about the means.
hybrid yield for this combination of cell types. However, each
attempt involved different endothelial cell preparations of un-
specified vigor.
Intraspecific hybrids cannot be used for chromosome map-
ping in the usual way, because a chromosome originating in one
progenitor cannot usually be distinguished from its counterpart
originating in the other progenitor cell type of the same spe-
cies.- However, these intraspecific hybrids demonstrate that
VIIIR:Ag expression can be sustained in hybrid cells and sug-
gest that permissive interspecific hybrids may be feasible with
the right combination of progenitor cells.
The morphology and distribution of VIIIR:Ag in EA-hy 926
cells and in primary endothelial cells are indistinguishable.
Therefore, it can be expected that the process by which this
antigen is accumulated intracellularly, the process by which it
is released, and perhaps even the manner in which its release
is regulated will be faithfully reflected in the continuously pro-
liferating hybrid cells. Permanent cell lines that express dif-
ferentiated functions like VIIIR:Ag are valuable because they
can be manipulated in vitro in ways that are impossible or im-
practical or unethical in vivo, they can be cryologically pre-
served, and they represent an economical continuous supply of
homogenous cellular material for structural, functional, and
regulatory studies.
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